mesothelioma

(redirected from mesotheliomas)
Also found in: Thesaurus, Medical, Encyclopedia.

mes·o·the·li·o·ma

 (mĕz′ə-thē′lē-ō′mə, mĕs′-, mē′zə-, -sə-)
n. pl. mes·o·the·li·o·ma·ta (-mə-tə) or mes·o·the·li·o·mas
A usually malignant tumor of mesothelial tissue, especially that of the pleura or peritoneum.

mesothelioma

(ˌmɛzəʊˌθiːlɪˈəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) a tumour of the epithelium lining the lungs, abdomen, or heart: often associated with exposure to asbestos dust
[C20: from mesotheli(um) + -oma]

mes•o•the•li•o•ma

(ˌmɛz əˌθi liˈoʊ mə, ˌmɛs-, ˈmi zə-, -sə-)

n., pl. -mas, -ma•ta (-mə tə)
a malignant tumor of the covering of the lung or the lining of the pleural and abdominal cavities, often associated with exposure to asbestos.
[1905–10]

mesothelioma

a rare malignant tumor that may invade the linings of the lungs and the abdomen. Also called celiothelioma.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.mesothelioma - a form of carcinoma of the mesothelium lining lungs or abdomen or heartmesothelioma - a form of carcinoma of the mesothelium lining lungs or abdomen or heart; usually associated with exposure to asbestos dust
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
Translations
mezoteliom
mésothéliome

mesothelioma

n mesotelioma m
References in periodicals archive ?
Recent molecular studies have demonstrated that mesotheliomas commonly show mutation or deletion of cyclin-dependent kinase inhibitor 2A (CDKN2A, p16) and BRCA-associated protein-1 (BAP1), and this information has been exploited through the use of p16 fluorescence in situ hybridization (FISH) analysis and BAP1 immunohistochemistry, where loss of either marker is a reliable indicator that a mesothelial proliferation is malignant.
The biphasic (mixed) subtype is the second most common histologic type accounting for 20-35% of all malignant pleural mesotheliomas (MPM).
Malignant mesothelioma represents 30% of all mesotheliomas [2] and it can be localized or diffuse.
Histologically malignant pleural mesotheliomas (MPM) are classified as epithelial (50%), sarcomatoid (15%) & biphasic (35%).
20% to 33% of all mesotheliomas (one fifth to one third) arise from the peritoneum.
8] The histopathologic differential diagnoses of malignant urogenital mesotheliomas includes metastatic adenocarcinoma, papillary mesothelial hyperplasia, carcinoma of the rete testis and embryonal carcinoma.
1) Nearly 85% of all mesotheliomas arise from the pleura, while approximately 9% arise in the peritoneum.
Inhaled asbestos fibers may contribute to three-fourths of malignant mesotheliomas diagnosed in men and almost 40% of cases diagnosed in women.
About three-fourths of mesotheliomas start in the chest cavity.
In fact, p53 is infrequently mutated in mesotheliomas, (15) and what has been described as positivity for p53 in mesotheliomas is, in retrospect, probably a mixture of a (mostly) normal and an occasional abnormal immunophenotype.
Occupational and environmental asbestos exposure may cause asbestosis (evolutive lung fibrosis), pleura/fibrosis and calcification, lung cancer, and mesotheliomas, with a risk proportional to the duration and intensity of exposure (Antman 1993; Magnani et al.
GLUT-1 shows focal positivity in 67% of mesotheliomas and in 3% of reactive lesions, while IMP3 shows more diffuse positivity in 73% of mesotheliomas and negativity in reactive lesions.